To conduct phase i, II, III or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task…
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N94020D00011
- Awardee
-
Cincinnati Univ Of UEI DZ4YCZ3QSPR5
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $280,399 obligated
Award facts
- Opportunity
-
- RFPNIHNICHDCDP20201 Solicitation number
- Combined order value
- $280,399 Current and potential, with all options
- Last date to order 89% complete
- IDV ceiling 6% used
- $5,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 18 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Child Health and Human Development awarded an indefinite-delivery contract to Cincinnati University of (Sponsored Research Services Division) with a $5 million ceiling on August 1, 2020, as one of multiple awards under the Contraceptive Development Program NICHD Contraceptive Clinical Trials Network—Female Sites program. Place of performance is Cincinnati, Ohio.
The IDIQ funds Phase I, II, III, and IV contraceptive trials in women, treatment trials of gynecologic conditions including endometriosis and leiomyomata, and development of research protocols on a task-order basis. The period of performance runs seven years through July 31, 2027.
Task-order activity under this vehicle includes a $89,542.23 delivery order issued August 1, 2020 (Task Order 1) for assistance in protocol review, protocol development, and activities associated with past, present, and future Contraceptive Clinical Trials Network activities with a severable scope and cost-no-fee pricing. A $190,857 delivery order was issued September 28, 2023 for protocol finalization, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the Ovaprene vaginal device clinical trial, with completion targeted December 31, 2025. Both orders specify cost-no-fee pricing and Cincinnati, Ohio as the place of performance.
Description
To conduct phase i, II, III or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task order basis under a seven (7) year indefinite-delivery
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N94020D00011?
75N94020D00011 was awarded to Cincinnati Univ Of by National Institute of Child Health and Human Development (National Institutes of Health) on August 1, 2020.
How much is contract 75N94020D00011 worth?
Orders under 75N94020D00011 have obligated $280,399. 75N94020D00011's own ceiling is $5,000,000.
How many orders have been placed under contract 75N94020D00011?
2 orders have been placed under 75N94020D00011, the latest on September 28, 2023.
Who can order from contract 75N94020D00011?
75N94020D00011 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N94020D00011 competed?
The extent of competition for 75N94020D00011 was full and open competition. The government received 18 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV